Finding 381091 (2023-006)

Significant Deficiency Repeat Finding
Requirement
L
Questioned Costs
-
Year
2023
Accepted
2024-03-19

AI Summary

  • Core Issue: Reports submitted lacked documented reviews, risking compliance with requirements.
  • Impacted Requirements: Internal controls for detecting noncompliance are not in place as per Uniform Guidance.
  • Recommended Follow-Up: Management should create procedures to ensure all financial and performance reports are reviewed and documented before submission.

Finding Text

Condition: Our testwork over the reporting compliance requirement included a sample of annual and quarterly financial and performance reports. We noted that the reports did not have a documented review of the reports prior to submission. Criteria: The Uniform Guidance requires organizations to establish internal controls to detect potential noncompliance. Cause: Overall lack of policies and procedures regarding retention of review documentation. Effect: Non-compliance with adequate review over required financial and program reports. Recommendation: We recommend that management establish procedures to document the review and approval of the required financial and performance reports. Views of Responsible Officials and Planned Corrective Actions: The reports to the CDC are provided in quarterly meetings. We were able to provide these reports to the Auditors and are now receiving these reports from the program office so that they can be maintained in a file which can be used for audit purposes.

Corrective Action Plan

The reports to the CDC are provided in quarterly meetings. We were able to provide these reports to the Auditors and are now receiving these reports from the program office so that they can be maintained in a file which can be used for audit purposes.

Categories

Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

  • 381087 2023-002
    Material Weakness
  • 381088 2023-003
    Material Weakness
  • 381089 2023-004
    Material Weakness Repeat
  • 381090 2023-005
    Significant Deficiency
  • 957529 2023-002
    Material Weakness
  • 957530 2023-003
    Material Weakness
  • 957531 2023-004
    Material Weakness Repeat
  • 957532 2023-005
    Significant Deficiency
  • 957533 2023-006
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
93.850 Improving Epilepsy Programs, Services, and Outcomes Through National Partnerships $3.86M